Norma Bonazzi, Emilia Fortunati, Lucia Zanoni, Giulia Argalia, Diletta Calabrò, Elena Tabacchi, Vincenzo Allegri, Davide Campana, Elisa Andrini, Giuseppe Lamberti, Martina Di Franco, Riccardo Casadei, Claudio Ricci, Cristina Mosconi, Stefano Fanti, Valentina Ambrosini
The recent introduction of novel treatments for advanced neuroendocrine tumors (NETs) and the well-established impact of clinical case discussion within dedicated multidisciplinary teams indicates the need to promote the centralization of rare diseases, such as NENs (neuroendocrine neoplasms). Data on the real-life use of and indications for [68Ga]Ga-DOTANOC PET/CT were collected from a prospective monocentric 5-year electronic archive including consecutive patients with confirmed and suspected NETs (September 2017 to May 2022)...
February 7, 2024: Cancers